Metabolix and the Korean industrial biotech company CJ CheilJedang (CJ) announced on 27th July the execution of a joint development agreement to advance production technology and assess investment options for the commercialization of renewable polyhydroxyalkanoates (PHA)-based C4 chemicals — initially butanediol (BDO), tetrahydrofuran (THF), gamma butyrolactone (GBL) and polyester engineering resins (PBT) via fermentation. The C4 chemical market is a $3 billion industry growing at 4 percent per year. C4 chemical products are used in a wide range of applications including engineering plastics, fabrics and fibers, personal care products and in semiconductor manufacturing. Under the joint development agreement, CJ will… Login to continue

Login or sign up